Literature DB >> 8532070

Bombesin-induced contractions of guinea pig lung strips are modulated by endogenous nitric oxide.

E Lach1, L Daeffler, F Waeldelé, J P Gies.   

Abstract

We have investigated the effects of a nitric oxide (NO) biosynthesis inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) on the bombesin-evoked contraction of guinea pig parenchymal lung strips. The bombesin-induced contractions of lung strips were significantly increased after L-NAME (300 micro)) pre-treatment. The maximal response was increased (P < 0.01) by 37% after L-NAME treatment when compared with the control group. The pD2 value was not influenced by L-NAME pre-treatment. The enhancement of the bombesin-induced contraction caused by L-NAME was reversed by addition of an excess of the NO precursor L-arginine (600 microM) but not by the addition of its inactive enantiomer D-arginine (600 microM). Like L-NAME, methylene blue (1 microM), an agent that inhibits the soluble guanylyl cyclase activated by NO, significantly increased (P < 0.01) the maximal contraction induced by bombesin (183 +/- 16 mg) when compared with the control group (141 +/- 15 mg). When tested against other agonist-induced contractions, L-NAME did not change the responsiveness of parenchymal lung strips to bradykinin or carbachol but significantly increased lung contraction induced by histamine. NO synthesis inhibition resulted in a pronounced increase in the bombesin-induced contraction of guinea-pig lung strips. Our results suggest that bombesin contributes to NO synthesis and release which then acts to reduce the contraction of the lungstrip in response to bombesin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532070     DOI: 10.1007/bf00172779

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Bombesin-induced bronchoconstriction in the guinea pig: mode of action.

Authors:  M G Belvisi; C D Stretton; P J Barnes
Journal:  J Pharmacol Exp Ther       Date:  1991-07-01       Impact factor: 4.030

Review 2.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

3.  Nitric oxide synthase in guinea pig lower airway innervation.

Authors:  A Fischer; P Mundel; B Mayer; U Preissler; B Philippin; W Kummer
Journal:  Neurosci Lett       Date:  1993-01-12       Impact factor: 3.046

Review 4.  The biology of nitrogen oxides in the airways.

Authors:  B Gaston; J M Drazen; J Loscalzo; J S Stamler
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

5.  Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium.

Authors:  F P Nijkamp; H J van der Linde; G Folkerts
Journal:  Am Rev Respir Dis       Date:  1993-09

6.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells.

Authors:  J C Willey; J F Lechner; C C Harris
Journal:  Exp Cell Res       Date:  1984-07       Impact factor: 3.905

7.  Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors.

Authors:  E Lach; E B Haddad; J P Gies
Journal:  Am J Physiol       Date:  1993-01

8.  Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.

Authors:  M Hecker; J A Mitchell; H J Harris; M Katsura; C Thiemermann; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

9.  Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.

Authors:  V Schlemper; J B Calixto
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo.

Authors:  R O Salonen; S E Webber; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.